NCT05325450 Optimization of Hearing Performance in the Subject Implanted
| NCT ID | NCT05325450 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Toulouse |
| Condition | Hearing Loss |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-05-18 |
| Primary Completion | 2027-01-18 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2023-05-18 with a primary completion date of 2027-01-18.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In the past two decades, the selection criteria for cochlear implantation have been greatly relaxed so that about 60-70% of present cochlear implant (CI) candidates have significant residual hearing in their contralateral ear. However, contralateral hearing is often not considered in rehabilitation programs, mainly due to the lack of scientific evidence on the role it may play. The present project aims to better understand the mechanisms of perceptual learning of CI-processed speech after implantation and to develop and test rehabilitation strategies for CI users.
Eligibility Criteria
Inclusion Criteria: * Age\>18 * Unilaterally postlingually-deafened adult cochlear implanted candidates (IC-Uni) * Person with almost normal or moderate contralateral hearing ( under 60dB) * Cochlear implanted person whose activation has not yet been performed * Cochlear implanted subjects with bilateral post-lingual profound deafness, who already benefit from a unilateral cochlear implant and candidates to a bilateral cochlear implant * Affiliated to social security Exclusion Criteria: * \- Subjects under juridical protections or tutelage measure * Subjects with associated neurological or neurodegenerative conditions * Significant anatomical changes on CT scan of the temporal bone that may interfere with the insertion of the cochlear implant
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05325450 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hearing Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05325450 currently recruiting?
Yes, NCT05325450 is actively recruiting participants. Contact the research team at marx.m@chu-toulouse.fr for enrollment information.
Where is the NCT05325450 trial being conducted?
This trial is being conducted at Toulouse, France.
Who is sponsoring the NCT05325450 clinical trial?
NCT05325450 is sponsored by University Hospital, Toulouse. The trial plans to enroll 50 participants.